PT Merck Terbuka Company Profile - Aug 12, 2011 by WrightReports

VIEWS: 68 PAGES: 10

More Info
									Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   PT Merck Terbuka
                                                                                        440 Wheelers Farms Road
                                                                                        Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in Indonesian Rupiahs

                                 Wright Quality Rating:LBA15                              Key Data

   PT Merck Tbk is an Indonesia-based pharmaceutical and chemicals company. It is         Ticker:
   mainly engaged in the manufacture of different formulations such as tablets,           MERK
   capsules, sterile solutions, oral drops and liquids, nasal drops and sprays, and
   creams. The Company operates two business segments: pharmaceutical segment,            2010 Sales:
   which includes the production and marketing of over-the-counter and prescription
                                                                                          795,688,800,000
   ethical products, and chemicals segment, which covers the marketing and
   distribution of chemicals, reagents, instrument and test kits, pigments and other
   specialty chemicals. Its chemical products are used in printing materials, plastic     Major Industry:
   materials, coating, cosmetics and in food. Its brands include Sangobion, Neurobion     Drugs, Cosmetics & Health
   and Glucophage. The Company is part of the Merck Group, Germany.                       Care
                         Stock Chart                                   Officers
                                                               President Commissioner     Sub Industry:
                                                                Klaus-Reinhard Bischoff   Ethical Drug Manufacturers

                                                                      President           Country:
                                                                    Ralf Annasentz        Indonesia

                                                                                          Currency:
                                                                                          Indonesian Rupiahs

                                                                                          Fiscal Year Ends:
                                                                                          December

                                                                                          Employees
                                                                                          828

                                                                                          Exchanges:
                                                                                          JAK

           Stock Price (8/5/2011): 127,000.00                                             Share Type:
                Recent stock performance
                                                                                          Ordinary
                    1 Week       2.8%
                    4 Weeks      3.3%
                    13 Weeks   26.4%                                                      Market Capitalization:
                    52 Weeks   74.0%                                                      2,844,800,000,000
                        Earnings / Dividends (as of 3/31/2011)
                                                                                          Total Shares
                                              Earnings           Dividends
                                                                              
								
To top